Product Code: ETC416997 | Publication Date: Oct 2022 | Updated Date: Jan 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
USA Buprenorphine market currently, in 2023, has witnessed an HHI of 3594, Which has increased slightly as compared to the HHI of 2663 in 2017. The market is moving towards concentrated. Herfindahl index measures the competitiveness of exporting countries. The range lies from 0 to 10000, where a lower index number represents a larger number of players or exporting countries in the market while a large index number means fewer numbers of players or countries exporting in the market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Buprenorphine Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Buprenorphine Market - Industry Life Cycle |
3.4 United States (US) Buprenorphine Market - Porter's Five Forces |
3.5 United States (US) Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 United States (US) Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 United States (US) Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United States (US) Buprenorphine Market Trends |
6 United States (US) Buprenorphine Market, By Types |
6.1 United States (US) Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Buprenorphine Market Revenues & Volume, By Application, 2018 - 2031F |
6.1.3 United States (US) Buprenorphine Market Revenues & Volume, By Analgesic, 2018 - 2031F |
6.1.4 United States (US) Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2018 - 2031F |
6.2 United States (US) Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Buprenorphine Market Revenues & Volume, By Injectables, 2018 - 2031F |
6.2.3 United States (US) Buprenorphine Market Revenues & Volume, By Sublingual, 2018 - 2031F |
6.2.4 United States (US) Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2018 - 2031F |
6.3 United States (US) Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2018 - 2031F |
6.3.3 United States (US) Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2018 - 2031F |
6.3.4 United States (US) Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2018 - 2031F |
7 United States (US) Buprenorphine Market Import-Export Trade Statistics |
7.1 United States (US) Buprenorphine Market Export to Major Countries |
7.2 United States (US) Buprenorphine Market Imports from Major Countries |
8 United States (US) Buprenorphine Market Key Performance Indicators |
9 United States (US) Buprenorphine Market - Opportunity Assessment |
9.1 United States (US) Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 United States (US) Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 United States (US) Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Buprenorphine Market - Competitive Landscape |
10.1 United States (US) Buprenorphine Market Revenue Share, By Companies, 2021 |
10.2 United States (US) Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |